0001348362-18-000002.txt : 20181115 0001348362-18-000002.hdr.sgml : 20181115 20181115162454 ACCESSION NUMBER: 0001348362-18-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20181115 DATE AS OF CHANGE: 20181115 EFFECTIVENESS DATE: 20181115 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Lexaria Bioscience Corp. CENTRAL INDEX KEY: 0001348362 STANDARD INDUSTRIAL CLASSIFICATION: METAL MINING [1000] IRS NUMBER: 202000871 STATE OF INCORPORATION: NV FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-325948 FILM NUMBER: 181187518 BUSINESS ADDRESS: STREET 1: 156 VALLEYVIEW ROAD CITY: KELOWNA STATE: A1 ZIP: V1X 3M4 BUSINESS PHONE: 250-765-6424 MAIL ADDRESS: STREET 1: 156 VALLEYVIEW ROAD CITY: KELOWNA STATE: A1 ZIP: V1X 3M4 FORMER COMPANY: FORMER CONFORMED NAME: LEXARIA CORP. DATE OF NAME CHANGE: 20080229 FORMER COMPANY: FORMER CONFORMED NAME: Lexaria Corp. DATE OF NAME CHANGE: 20051229 D 1 primary_doc.xml X0708 D LIVE 0001348362 Lexaria Bioscience Corp. 156 VALLEYVIEW ROAD KELOWNA A1 BRITISH COLUMBIA, CANADA V1X 3M4 250-765-6424 NEVADA LEXARIA CORP. Lexaria Corp. Corporation true Christopher Bunka 156 Valleyview Road Kelowna A1 BRITISH COLUMBIA, CANADA V1X 3M4 Executive Officer Director John Martin Docherty 156 Valleyview Road Kelowna A1 BRITISH COLUMBIA, CANADA V1X 3M4 Executive Officer Director Nicholas W. Baxter 220 Springfield Road Aberdeen, Scotland X0 UNITED KINGDOM AB15 6AU Director Ted McKechnie 305 Margaret Avenue Suite 707 Kitchener A6 ONTARIO, CANADA N2H 6S4 Director Allan Spissinger 156 Valleyview Road Kelowna A1 BRITISH COLUMBIA, CANADA V1X 3M4 Executive Officer Pharmaceuticals $1 - $1,000,000 06c false 2018-10-31 false true true false 0 310000 310000 0 false 3 0 0 0 false Lexaria Bioscience Corp. /s/ Chris Bunka Chris Bunka CEO/Director 2018-11-15